robert.burford@aptuit.com |
Robert G. Burford, Ph.D., FACAManaging Director
- New product development strategies
- Toxicology/pharmacology
- Clinical research management
- Regulatory strategies
- Cardiovascular, CNS (Alzheimer’s)
|
bill.kerns@aptuit.com |
William D. Kerns DVM, MS, DACVP
Managing Director
- Managing drug development-API through Phase 2 POC
- Regulatory planning and IND submissions
- Expert witnessing for biological issues
- Due diligence for investment firms and pharma companies
- Cardiovascular drug safety
|
leslie.patmore@aptuit.com |
Leslie Patmore, Ph.D.
Managing Director
- Drug Development Strategy and Management
- Lead Candidate Optimisation
- Safety Pharmacology
- QT Prolongation Risk Assessment
- Preclinical Safety Assessment
|
jeffrey.wilson@aptuit.com |
Jeffrey Wilson, Ph.D.
Managing Director
- Active pharmaceutical ingredient and drug product R&D
- Clinical trials supply
- CMC Regulatory strategy
- Analytical method development and validation
- Supply chain management
|
marc.cote@aptuit.com |
Marc R. Cote
Chief Operating Officer
- Operational management and expansion
- Finance liaison
- Acquisition management and integration
- Systems implementation liaison
|